# Safety Study of Cenderitide in Stable Chronic Heart Failure

> **NCT02359227** · PHASE2 · COMPLETED · sponsor: **Capricor Inc.** · enrollment: 14 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Cenderitide

## Key facts

- **NCT ID:** NCT02359227
- **Lead sponsor:** Capricor Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-04-02
- **Final completion:** 2015-04-02
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02359227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02359227, "Safety Study of Cenderitide in Stable Chronic Heart Failure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02359227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*